Bacteremia Caused by Group G Streptococci, Taiwan

A retrospective observational study in Taiwan, 1998–2004, identified 92 patients with group G streptococcal bacteremia; 86 had Streptococcus dysgalactiae subspecies equisimilis. The most common diagnosis was cellulitis (48 cases), followed by primary bacteremia (34 cases). Infection recurred in 9 patients. Mortality rate was low (3.3%); resistance to quinupristin-dalfopristin was high.


The Study
We included all patients with GGS-positive blood cultures who had been treated from April 1998 through August 2004 at National Taiwan University Hospital, a 2,000-bed teaching hospital in northern Taiwan. We recorded demographic parameters, underlying illness, clinical diagnosis, and outcome for each patient. Clinical diagnosis was based on the attending physician's judgment and examination results. Recurrence of bacteremia was defi ned as repeated positive blood culture after complete treatment (at least 14 days) of previous bacteremia.
Differentiation of GGS was based on colony size, hemolytic reaction, Voges-Proskauer reaction, and β-glucuronidase activity. All β-hemolytic streptococci, whether large or small colonies, were tested for Lancefi eld group by using an agglutination kit (Streptex; Murex Bio-tech Ltd., Dartford, UK). PCR to differentiate between S. anginosus and S. dysgalactiae subsp. equisimilis was performed for all GGS isolates as described (7). For identifi cation of S. canis, a probable isolate was identifi ed by a negative β-glucuronidase result and further confi rmed with the 16sRNA method as described (8). Susceptibilities of these isolates were tested by using the broth microdilution method as defi ned by the Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory Standards) (9).
To determine the similarity of isolates in cases of recurrence, we used pulsed-fi eld gel electrophoresis (PFGE) as described (10). The emm typing of isolates in cases of recurrence were also determined as described (11). The fi rst 160 bases sequenced by emmseq2 that had >95% identity were defi ned as having the same genotype (11).
During the study period, 106 episodes of GGS bacteremia in 92 patients had been recorded; 56 episodes occurred during the fi rst half of the study period (before June 2001) and 50 episodes during the second half. The causative agent was S. dysgalactiae subsp. equisimilis for 99 episodes, S. anginosus for 5, and S. canis for 2. Bacteremia recurred for 9 patients (1 had 4 episodes, and 3 had 3 episodes); bacteremia was nosocomial for 7 patients and polymicrobial for 5. The clinical characteristics of the patients are summarized in Table 1. All 3 patients who died had a diagnosis of the primary bacteremia caused by S. dysgalactiae subsp. equisimilis.
Among the 9 patients with recurrent bacteremia, the causative agent was S. dysgalactiae subsp. equisimilis for 8 and S. canis for 1. PFGE performed with all 13 available isolates from recurrent cases showed that 10 were identical to that of the initial episode, including 1 in a patient with recurrence of S. canis bacteremia. Sequence typing showed emm type stG485 for 4 patients. The clinical characteristics of the patients and emm typing results are shown in Table  2; PFGE results are shown in the Figure. The underlying diseases of patients with recurrent episodes included genital cancer (4 [44.4%] patients) and history of cellulitis (6 [66.7%]), each of which was signifi cantly correlated with the likelihood of recurrence (p<0.01 for each). Further analysis showed that a previous history of cellulitis was signifi cantly correlated with female sex (p = 0.01), genital cancer (p<0.01), tissue edema (p = 0.02), heart disease (p = 0.04), and post-coronary artery bypass graft (p = 0.03).
Bacteremia caused by β-hemolytic S. anginosus with group G antigen was identifi ed for 5 patients, none of whom had cellulitis, compared with 48 (55.8%) of the 86 patients with S. dysgalactiae subsp. equisimilis who did have cellulitis (p = 0.03). Polymicrobial bacteremia and nosocomial bacteremia were found in a higher percentage of patients with S. anginosus (60% and 40.0%, respectively) than of patients with S. dysgalactiae subsp. equisimilis bacteremia (4.7% and 5.8%, respectively); p<0.01 and p = 0.02, respectively. The 1 patient with S. canis bacteremia was a 33year-old man with no history of dog bite. He had alcoholassociated liver cirrhosis of Child C (severe) classifi cation and leg edema. He had 2 episodes of S. canis bacteremia 1 month apart. Echocardiogram results showed no evidence of valvular vegetation. For the fi rst episode, the patient received a 14-day course of cefotaxime.

Conclusions
We documented 5 cases of primary bacteremia caused by β-hemolytic group G S. anginosus and unintentionally documented recurrence of S. canis bacteremia. S. canis bacteremia in humans was fi rst clearly described in 1997 (12).
Our fi nding of 5 β-hemolytic S. anginosus isolates and 1 S. canis isolate in patients with GGS bacteremia in this study differs from fi ndings of previous studies (2,3). Factors that may have contributed to this discrepancy include serotype determination and PCR method. Serotype determination was performed for all β-hemolytic streptococci isolated in our hospital, whether colonies were large or small, which might have led to the detection of more streptococcal isolates with G antigen. The PCR method developed in our hospital and used in this study could effectively differentiate S. anginosus from S. dysgalactiae subsp. equisimilis (7).
Information about clinical infection with S. milleri with group G antigen is limited (4). In a previous study of GGS bacteremia, Cohen-Poradosu et al. reported that 6 of 84 patients had recurrence of bacteremia (3). We found recurrence in 9 of the 92 patients. Risk factors were similar to those previously reported for non-group A streptococcal cellulitis (13). PFGE of these isolates showed that a high percentage of recurrence was caused by identical strains. Although Cohen-Poradosu et al. reported that emm type stG840 was the most common strain (3), we found emm type stG485 to be most common.

DISPATCHES 838
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 5, May 2008  Table 2). Lane M, molecular mass marker For years in Taiwan, macrolide resistance of streptococci has been a major health problem (14,15). A previous study found erythromycin resistance in 23.5% of GGS strains (14). Although we did not test for erythromycin resistance, we found some resistance even to new macrolides. Since restriction of macrolide use in Taiwan, a linear relationship has been noted between the decline in erythromycin use and the decline in erythromycin resistance in S. pyogenes (15). Our study, however, found no decline in macrolide resistance from fi rst half of the study period (27.1%) to the second half (37.0%).
In summary, in our study, infection with S. dysgalactiae subsp. equisimilis was the most common cause of GGS bacteremia. Infection recurred for ≈10%. The mortality rate for patients with GGS bacteremia was relatively low (<10%), but resistance to quinupristin-dalfopristin was extremely high.
Dr Liao is an infectious diseases specialist in the Department of Internal Medicine, Far-Eastern Memorial Hospital. His major research interests are clinical and epidemiologic studies and pathogenesis of gram-positive bacterial infections, particularly streptococcal and methicillin-resistant Staphylococcus aureus infections.